Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The evolving pathogenesis of systemic vasculitis.

Caroline O S Savage1

  • 1Division of Medical Sciences, University of Birmingham, Edgbaston. C.O.S.Savage@bham.ac.uk

Clinical Medicine (London, England)
|November 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depletion of LAG-3<sup>+</sup> T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781.

Clinical pharmacology and therapeutics·2020
Same author

ANCA-associated vasculitis.

Nature reviews. Disease primers·2020
Same author

Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry.

Frontiers in immunology·2019
Same author

Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.

Journal of proteome research·2015
Same author

Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk.

Journal of immunology (Baltimore, Md. : 1950)·2014
Same author

Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney.

PloS one·2013
Same journal

Premature ventricular complexes.

Clinical medicine (London, England)·2026
Same journal

Heart failure with preserved ejection fraction (HFpEF): diagnosis and management for the general physician.

Clinical medicine (London, England)·2026
Same journal

Trends and Widening Inequities in Cardiovascular-Kidney-Metabolic Involvement in Cardiovascular Mortality: A National Spatiotemporal Analysis, 2014-2023.

Clinical medicine (London, England)·2026
Same journal

Educating current and future healthcare professionals on evidence-based sustainable medicine.

Clinical medicine (London, England)·2026
Same journal

UK Foundation Programme training needs a national minimum standard for advanced life support.

Clinical medicine (London, England)·2026
Same journal

Prognostic value of left atrial diameter in chronic kidney disease: The KNOW-CKD study.

Clinical medicine (London, England)·2026
See all related articles

Small vessel systemic vasculitides involve inflammation of small blood vessels, often affecting lungs and kidneys. Targeting tumor necrosis factor (TNF) offers a potential therapeutic strategy by mitigating neutrophil and endothelial cell damage.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathology

Background:

  • Small vessel systemic vasculitides are autoimmune disorders characterized by inflammation of small blood vessels.
  • These conditions are associated with antineutrophil cytoplasmic antibodies and can affect multiple organs, notably the lungs and kidneys.
  • Current understanding suggests inappropriate neutrophil activation by antibodies contributes to endothelial and vascular damage.

Purpose of the Study:

  • To elucidate the pathogenic mechanisms underlying small vessel systemic vasculitides.
  • To explore the role of cytokines, such as tumor necrosis factor (TNF), in disease progression.
  • To identify potential therapeutic targets based on a deeper understanding of pathogenesis.

Main Methods:

  • Review of existing literature on small vessel systemic vasculitides pathogenesis.

Related Experiment Videos

  • Analysis of the role of antineutrophil cytoplasmic antibodies in neutrophil activation.
  • Investigation of cytokine-mediated effects on neutrophils and endothelial cells.

    • Main Results:

    • Antineutrophil cytoplasmic antibodies inappropriately activate neutrophils, causing endothelial and vascular damage.
    • Tumor necrosis factor (TNF) primes neutrophils and activates endothelial cells, exacerbating damage.
    • Pathogenic insights highlight the potential for anti-TNF therapies.

    Conclusions:

    • Understanding the pathogenesis of small vessel systemic vasculitides is crucial for rationalizing current treatments.
    • Inhibition of tumor necrosis factor (TNF) represents a promising therapeutic avenue for these disorders.
    • Further research into pathogenic pathways may reveal novel treatment strategies.